The Use of Biologic Modifiers as a Bridge to Hematopoietic Cell Transplantation in Primary Immune Regulatory Disorders

New Research: The Use of Biologic Modifiers as a Bridge to Hematopoietic Cell Transplantation in Primary Immune Regulatory Disorders: Recently, primary immune regulatory disorders have been described as a subset of inborn errors of immunity… https://t.co/o

The Use of Biologic Modifiers as a Bridge to Hematopoietic Cell Transplantation in Primary Immune Regulatory Disorders #PID #bmt #johnshopkins #medtwitter #allchildrens https://t.co/YRZn3qHnat